IL-28B/IFN-λ3 Recombinant Rabbit mAb (SDT-1838-77-2)

產(chǎn)品型號：S0B3407

更新時間：2025-06-29

廠商性質(zhì)：生產(chǎn)廠家

訪問量：35

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

斯達(dá)特HbA1c配對抗體：為糖尿病研究與臨床診斷提供原料

PD-L1 IHC抗體

IHC腫瘤標(biāo)志物 | 常見胃癌和結(jié)直腸癌診斷

p16/Ki-67雙染：子宮頸癌前病變診斷的精準(zhǔn)之道

產(chǎn)品介紹

IL28B is a newly-discovered type III interferon, with antiviral, antiproliferative, and immunomodulatory functions. Type III IFNs share homology with IL-10 and the IL-10R2 receptor subunit, leading to the speculation that these cytokines might be evolutionarily related.
It was recently found that polymorphisms in IFN-lambda-4
（another type III interferon） are associated with circulating IL28B, and higher plasma IL28B are associated with higher production of antibodies to HBV surface antigen. IL28B is associated with the extent of lupus activity, in particular with active serosal and cutaneous disease. Combined treatment with IL28B and sorafenib （a small molecule multikinase inhibitor） facilitates a synergistic effect on suppressing hepatocellular carcinoma cancer growth and promoting
cell apoptosis in vitro and in vivo.

上一個：S0B3405IL-28B/IFN-λ3 Recombinant Rabbit mAb (SDT-1838-120)